A panel of experts discusses diabetes treatment management and the impact pharmacists can have on an increasingly diverse patient population.
As part of the Pharmacy Times Pharmacy Focus webcast series, a panel of experts discusses the effective management of diabetes treatment and how pharmacists can address the challenges of an increasingly diverse patient population. Among the topics are how pharmacists can work collaboratively with patients to make the best use of treatments and achieve optimal therapeutic outcomes and new treatment options for diabetes.
The expert panel includes moderator Curtis Triplitt PharmD, CDE, associate director, Diabetes Research Unit Texas Diabetes Institute, University Health System, clinical associate professor, Medicine/Diabetes University of Texas Health Science Center at San Antonio; Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, FAPhA, associate professor of Pharmacy Practice, Drake University; Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, vice-chair and Allen I. White Distinguished Professor, Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University; Susan Cornell, BS, PharmD, CDCES, FAPhA, FADCES, associate director of Experiential Education, professor of Pharmacy Practice, Midwestern University College of Pharmacy Downers Grove.
The discussion included how pharmacists can work collaboratively with patients to make the best use of treatments to achieve optimal therapeutic outcomes, new treatment options for diabetes, SGLT2 inhibitors versus GLP-1 receptor agonists, long-term implications of semaglutide approval for weight loss on individuals at-risk of diabetes, and how pharmacists can help patients manage the cost of treatment.